 |
|
|
| |
The burden of chronic hepatitis delta in Italy: potential impacts and effects of bulevirtide through Cost of Illness and Cost Consequence Analysis
|
| |
| |
European Association for the Study of the Liver (EASL) 2024; June 5-8, 2024; Milan, Italy
Andrea Marcellusi1, Martina Paoletti1, Francesco Saverio Mennini1, Loreta Kondili2, Nicola Coppola3, Barbara Coco4, Alessandra Mecozzi5, Sara Mollea6, Chong Kim7, Marvin Rock7
|
| |
|
|
|
|
|
